Impact of prophylactic cytomegalovirus immunoglobulin on cytomegalovirus viremia and graft function in ABO-incompatible living donor kidney transplantation: a retrospective analysis.

Front Immunol · 2025 · PMC12066264 · PMID 40356931

Europe PMC DOI

hedged sentence

0.3830

closest p · 7.7× alpha

0.3830

boldest claim

The sentences

did not reach statistical significanceP = 0.383not close (p > 0.1)

Regarding treatment duration, the median course of preemptive antiviral therapy was shorter in the CMVig group (2 weeks, IQR: 2-4) compared to the PET group (3.5 weeks, IQR: 2-4), although this difference did not reach statistical significance (P = 0.383).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.